[go: up one dir, main page]

MX2018009254A - Metodos para evaluar el riesgo de desarrollar cancer colorrectal. - Google Patents

Metodos para evaluar el riesgo de desarrollar cancer colorrectal.

Info

Publication number
MX2018009254A
MX2018009254A MX2018009254A MX2018009254A MX2018009254A MX 2018009254 A MX2018009254 A MX 2018009254A MX 2018009254 A MX2018009254 A MX 2018009254A MX 2018009254 A MX2018009254 A MX 2018009254A MX 2018009254 A MX2018009254 A MX 2018009254A
Authority
MX
Mexico
Prior art keywords
methods
colorectal cancer
developing colorectal
risk
assessing risk
Prior art date
Application number
MX2018009254A
Other languages
English (en)
Inventor
Jenkins Mark
Buchanan Daniel
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016900254A external-priority patent/AU2016900254A0/en
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of MX2018009254A publication Critical patent/MX2018009254A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

La presente descripción se refiere a métodos y sistemas para evaluar el riesgo de un sujeto humano para desarrollar cáncer colorrectal. Estos métodos se pueden combinar con el riesgo clínico de los sujetos para mejorar el análisis de riesgo. Tales métodos se pueden usar para ayudar a tomar decisiones sobre los regímenes de pruebas de detección del cáncer colorrectal adecuados.
MX2018009254A 2016-01-28 2017-01-27 Metodos para evaluar el riesgo de desarrollar cancer colorrectal. MX2018009254A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2016900254A AU2016900254A0 (en) 2016-01-28 Methods for assessing risk of developing colorectal cancer
AU2016903246A AU2016903246A0 (en) 2016-08-16 Methods for assessing risk of developing colorectal cancer
PCT/AU2017/050066 WO2017127893A1 (en) 2016-01-28 2017-01-27 Methods for assessing risk of developing colorectal cancer

Publications (1)

Publication Number Publication Date
MX2018009254A true MX2018009254A (es) 2019-05-06

Family

ID=59396853

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009254A MX2018009254A (es) 2016-01-28 2017-01-27 Metodos para evaluar el riesgo de desarrollar cancer colorrectal.

Country Status (12)

Country Link
US (1) US11773448B2 (es)
EP (1) EP3408412B1 (es)
JP (2) JP7126704B2 (es)
KR (1) KR20180123480A (es)
CN (1) CN109072308A (es)
AU (1) AU2017212152B2 (es)
CA (1) CA3012783A1 (es)
ES (1) ES2976360T3 (es)
IL (1) IL260777B (es)
MX (1) MX2018009254A (es)
SG (1) SG11201806432PA (es)
WO (1) WO2017127893A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7101143B2 (ja) * 2019-04-23 2022-07-14 ジェネシスヘルスケア株式会社 大腸がんのリスクを判定する方法
CN111057767A (zh) * 2020-01-19 2020-04-24 北京市第一中西医结合医院 一种中国人胃肠道肿瘤风险相关的位于mlh1基因的snp位点及其应用
CN111739642A (zh) * 2020-06-23 2020-10-02 杭州和壹医学检验所有限公司 一种结直肠癌风险预测方法、系统、计算机设备及可读存储介质
CN112029852B (zh) * 2020-09-24 2023-12-05 吉林大学 ONFH易感相关TNF-α、GREM1、TGF-β、CR2基因SNP检测物质
CN114672556A (zh) * 2020-12-25 2022-06-28 上海善准生物科技有限公司 结直肠癌分子分型及生存风险基因群及诊断产品和应用
CN114334142A (zh) * 2021-07-02 2022-04-12 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种用于结直肠癌发病风险预测的snp位点组合、发病风险预测模型及系统
CN115786501B (zh) * 2022-07-02 2023-06-16 武汉大学 一种与结直肠癌早期筛查和辅助诊断相关的增强子功能位点及其应用
AU2023417599A1 (en) * 2022-12-27 2025-07-10 Rhy Genetype Pty Ltd Colorectal cancer risk assessment
CN116949179A (zh) * 2023-07-04 2023-10-27 中国医学科学院北京协和医院 结直肠肿瘤多基因遗传风险评分系统、存储介质和电子设备
CN118658626A (zh) * 2024-08-19 2024-09-17 杭州和壹基因科技有限公司 一种基于机器学习的消化系统肿瘤的筛查方法及系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147035A (en) 1978-05-10 1979-11-16 Minolta Camera Co Ltd Tessar type photographic lens placed behind aperture
US4240608A (en) 1979-11-02 1980-12-23 Acf Industries, Incorporated Controlled float seat arrangement for expanding gate valves
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
DE69739357D1 (de) 1996-06-04 2009-05-28 Univ Utah Res Found Überwachung der hybridisierung während pcr
US6174170B1 (en) 1997-10-21 2001-01-16 Sony Corporation Display of text symbols associated with audio data reproducible from a recording disc
AU785425B2 (en) 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
WO2003021259A1 (en) 2001-09-05 2003-03-13 Perlegen Sciences, Inc. Selection of primer pairs
US6898531B2 (en) 2001-09-05 2005-05-24 Perlegen Sciences, Inc. Algorithms for selection of primer pairs
US20040023237A1 (en) 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US6897025B2 (en) 2002-01-07 2005-05-24 Perlegen Sciences, Inc. Genetic analysis systems and methods
US20050019787A1 (en) 2003-04-03 2005-01-27 Perlegen Sciences, Inc., A Delaware Corporation Apparatus and methods for analyzing and characterizing nucleic acid sequences
US20040241657A1 (en) 2003-05-28 2004-12-02 Perlegen Sciences, Inc. Liver related disease compositions and methods
US7127355B2 (en) 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
KR101206029B1 (ko) 2005-04-01 2012-11-28 삼성전자주식회사 대장암 진단용 다중 ｓｎｐ, 그를 포함하는 마이크로어레이및 키트 및 그를 이용한 대장암 진단 방법
CN102089443A (zh) * 2008-04-10 2011-06-08 基因信息公司 用于测定受试者中结肠直肠癌的概率的方法和装置
CN102876791B (zh) * 2012-09-21 2015-09-02 湖北维达健基因技术有限公司 一种用于肛肠疾病患病风险评估基因芯片、制备方法及其试剂盒
EP3207161A4 (en) * 2014-10-14 2018-09-12 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with cancer risk
US10609708B1 (en) 2017-06-27 2020-03-31 Sprint Spectrum L.P. Use of TDD special subframe for transmission of small quantity of data

Also Published As

Publication number Publication date
KR20180123480A (ko) 2018-11-16
ES2976360T3 (es) 2024-07-30
JP2019510473A (ja) 2019-04-18
EP3408412A1 (en) 2018-12-05
JP2022104934A (ja) 2022-07-12
IL260777A (es) 2018-09-20
AU2017212152B2 (en) 2019-07-11
US11773448B2 (en) 2023-10-03
EP3408412B1 (en) 2024-03-20
IL260777B (en) 2022-09-01
WO2017127893A1 (en) 2017-08-03
EP3408412A4 (en) 2020-01-15
JP7126704B2 (ja) 2022-08-29
SG11201806432PA (en) 2018-08-30
CN109072308A (zh) 2018-12-21
AU2017212152A1 (en) 2018-08-16
US20190161802A1 (en) 2019-05-30
CA3012783A1 (en) 2017-08-03

Similar Documents

Publication Publication Date Title
MX2018009254A (es) Metodos para evaluar el riesgo de desarrollar cancer colorrectal.
PH12019501146A1 (en) Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
CY1126115T1 (el) Συνδυασμος anti-lag-3 αντισωματων και anti-pd-1 αντισωματων για θεραπεια ογκων
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
IL262245B (en) Methods and kits for diagnosis and risk assessment for patients suffering from ischemia
IL260400B (en) Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
HUE053452T2 (hu) Anti-PD-1 és anti-LAG3 antitestek rák kezelésére
AU2016243120B2 (en) Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
EP3411505A4 (en) EVIDENCE OF CANCER DEVELOPMENT AND DIAGNOSTICS
PH12019501837A1 (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
MX2020010947A (es) Metodos de tratamiento de enfermedad de alzheimer.
SG10201907501QA (en) Antibodies and assays for detection of folate receptor 1
IL254639A0 (en) Digital analysis of cancer cells moving in the bloodstream in blood samples
EA201691866A1 (ru) Проникающие в опухоль лимфоциты для адоптивной клеточной терапии
WO2014190286A3 (en) Methods and processes for non-invasive assessment of genetic variations
PL3455631T3 (pl) Sposoby klasyfikowania pacjentów z nowotworem litym
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
MX2016012697A (es) Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.
IL281355B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
TW201614237A (en) Markers for identifying patients responsive to anti-PD-L1 antibody therapy
GB201820795D0 (en) Analysis of bodily fluids using infrared spectroscopy for the diagnosis and/or prognosis of cancer
EP3720337C0 (en) SPECTROREFLECTOMETRIC SYSTEM WITH POINTING MODE FOR COMBINED IMAGING AND SPECTRAL ANALYSIS
WO2015187727A3 (en) Molecular mammography